TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Healthcare-associated Infectious Disease Diagnostics Market Insights, Forecast to 2028

Global Healthcare-associated Infectious Disease Diagnostics Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 09 June 2022
  • Pages :112
  • Formats:
  • Report Code:SMR-7143570
OfferClick for best price

Best Price: $3920

Healthcareassociated Infectious Disease Diagnostics Market Size, Share 2022


Market Analysis and Insights: Global Healthcareassociated Infectious Disease Diagnostics Market

The global Healthcareassociated Infectious Disease Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Healthcareassociated Infectious Disease Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Healthcareassociated Infectious Disease Diagnostics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Healthcareassociated Infectious Disease Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Healthcareassociated Infectious Disease Diagnostics market.

Global Healthcareassociated Infectious Disease Diagnostics Scope and Market Size

Healthcare-associated Infectious Disease Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Healthcare-associated Infectious Disease Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Urinary Tract Infections

Surgical Site Infections

Hospital-acquired Pneumonia

BloodStream Infections

Gastrointestinal Infections

Segment by Application

Hospitals

Clinics

ASCs

By Company

Abbott

Accelerate Diagnostics

BD

bioMrieux

Bio-Rad

DiaSorin Molecular

F. Hoffmann-La Roche

Luminex

Meridian Bioscience

OpGen

QIAGEN

Quidel

Thermo Fisher Scientific

Trinity Biotech

Danaher

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Healthcareassociated Infectious Disease Diagnostics product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Healthcareassociated Infectious Disease Diagnostics, with price, sales, revenue, and global market share of Healthcareassociated Infectious Disease Diagnostics from 2019 to 2022.

Chapter 3, the Healthcareassociated Infectious Disease Diagnostics competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Healthcareassociated Infectious Disease Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Healthcareassociated Infectious Disease Diagnostics market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Healthcareassociated Infectious Disease Diagnostics.

Chapter 13, 14, and 15, to describe Healthcareassociated Infectious Disease Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Healthcareassociated Infectious Disease Diagnostics Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Healthcare-associated Infectious Disease Diagnostics Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 112 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Urinary Tract Infections
1.2.3 Surgical Site Infections
1.2.4 Hospital-acquired Pneumonia
1.2.5 BloodStream Infections
1.2.6 Gastrointestinal Infections
1.3 Market by Application
1.3.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 ASCs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Perspective (2017-2028)
2.2 Healthcare-associated Infectious Disease Diagnostics Growth Trends by Region
2.2.1 Healthcare-associated Infectious Disease Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Healthcare-associated Infectious Disease Diagnostics Market Dynamics
2.3.1 Healthcare-associated Infectious Disease Diagnostics Industry Trends
2.3.2 Healthcare-associated Infectious Disease Diagnostics Market Drivers
2.3.3 Healthcare-associated Infectious Disease Diagnostics Market Challenges
2.3.4 Healthcare-associated Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue
3.1.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Healthcare-associated Infectious Disease Diagnostics Revenue
3.4 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio
3.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Healthcare-associated Infectious Disease Diagnostics Revenue in 2021
3.5 Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Type
4.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2023-2028)
5 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Application
5.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
6.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
6.2.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
6.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
6.3.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
6.4 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
6.4.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type
7.2.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application
7.3.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
7.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country
7.4.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type
8.2.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application
8.3.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region
8.4.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
9.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
9.2.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
9.3.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
9.4.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type
10.2.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application
10.3.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country
10.4.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Introduction
11.1.4 Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Details
11.2.2 Accelerate Diagnostics Business Overview
11.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Introduction
11.2.4 Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.2.5 Accelerate Diagnostics Recent Developments
11.3 BD
11.3.1 BD Company Details
11.3.2 BD Business Overview
11.3.3 BD Healthcare-associated Infectious Disease Diagnostics Introduction
11.3.4 BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.3.5 BD Recent Developments
11.4 bioMrieux
11.4.1 bioMrieux Company Details
11.4.2 bioMrieux Business Overview
11.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Introduction
11.4.4 bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.4.5 bioMrieux Recent Developments
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Introduction
11.5.4 Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.5.5 Bio-Rad Recent Developments
11.6 DiaSorin Molecular
11.6.1 DiaSorin Molecular Company Details
11.6.2 DiaSorin Molecular Business Overview
11.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Introduction
11.6.4 DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.6.5 DiaSorin Molecular Recent Developments
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.7.5 F. Hoffmann-La Roche Recent Developments
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Introduction
11.8.4 Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.8.5 Luminex Recent Developments
11.9 Meridian Bioscience
11.9.1 Meridian Bioscience Company Details
11.9.2 Meridian Bioscience Business Overview
11.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Introduction
11.9.4 Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.9.5 Meridian Bioscience Recent Developments
11.10 OpGen
11.10.1 OpGen Company Details
11.10.2 OpGen Business Overview
11.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Introduction
11.10.4 OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.10.5 OpGen Recent Developments
11.11 QIAGEN
11.11.1 QIAGEN Company Details
11.11.2 QIAGEN Business Overview
11.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Introduction
11.11.4 QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.11.5 QIAGEN Recent Developments
11.12 Quidel
11.12.1 Quidel Company Details
11.12.2 Quidel Business Overview
11.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Introduction
11.12.4 Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.12.5 Quidel Recent Developments
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Details
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Introduction
11.13.4 Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.13.5 Thermo Fisher Scientific Recent Developments
11.14 Trinity Biotech
11.14.1 Trinity Biotech Company Details
11.14.2 Trinity Biotech Business Overview
11.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Introduction
11.14.4 Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.14.5 Trinity Biotech Recent Developments
11.15 Danaher
11.15.1 Danaher Company Details
11.15.2 Danaher Business Overview
11.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Introduction
11.15.4 Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.15.5 Danaher Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Urinary Tract Infections
Table 3. Key Players of Surgical Site Infections
Table 4. Key Players of Hospital-acquired Pneumonia
Table 5. Key Players of BloodStream Infections
Table 6. Key Players of Gastrointestinal Infections
Table 7. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2017-2022)
Table 11. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2023-2028)
Table 13. Healthcare-associated Infectious Disease Diagnostics Market Trends
Table 14. Healthcare-associated Infectious Disease Diagnostics Market Drivers
Table 15. Healthcare-associated Infectious Disease Diagnostics Market Challenges
Table 16. Healthcare-associated Infectious Disease Diagnostics Market Restraints
Table 17. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Players (2017-2022)
Table 19. Global Top Healthcare-associated Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2021)
Table 20. Ranking of Global Top Healthcare-associated Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
Table 24. Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2017-2022)
Table 28. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2023-2028)
Table 30. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Application (2017-2022)
Table 32. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Application (2023-2028)
Table 34. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Healthcare-associated Infectious Disease Diagnostics Product
Table 67. Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 68. Abbott Recent Developments
Table 69. Accelerate Diagnostics Company Details
Table 70. Accelerate Diagnostics Business Overview
Table 71. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product
Table 72. Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 73. Accelerate Diagnostics Recent Developments
Table 74. BD Company Details
Table 75. BD Business Overview
Table 76. BD Healthcare-associated Infectious Disease Diagnostics Product
Table 77. BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 78. BD Recent Developments
Table 79. bioMrieux Company Details
Table 80. bioMrieux Business Overview
Table 81. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product
Table 82. bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 83. bioMrieux Recent Developments
Table 84. Bio-Rad Company Details
Table 85. Bio-Rad Business Overview
Table 86. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product
Table 87. Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 88. Bio-Rad Recent Developments
Table 89. DiaSorin Molecular Company Details
Table 90. DiaSorin Molecular Business Overview
Table 91. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product
Table 92. DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 93. DiaSorin Molecular Recent Developments
Table 94. F. Hoffmann-La Roche Company Details
Table 95. F. Hoffmann-La Roche Business Overview
Table 96. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product
Table 97. F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 98. F. Hoffmann-La Roche Recent Developments
Table 99. Luminex Company Details
Table 100. Luminex Business Overview
Table 101. Luminex Healthcare-associated Infectious Disease Diagnostics Product
Table 102. Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 103. Luminex Recent Developments
Table 104. Meridian Bioscience Company Details
Table 105. Meridian Bioscience Business Overview
Table 106. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product
Table 107. Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 108. Meridian Bioscience Recent Developments
Table 109. OpGen Company Details
Table 110. OpGen Business Overview
Table 111. OpGen Healthcare-associated Infectious Disease Diagnostics Product
Table 112. OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 113. OpGen Recent Developments
Table 114. QIAGEN Company Details
Table 115. QIAGEN Business Overview
Table 116. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product
Table 117. QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 118. QIAGEN Recent Developments
Table 119. Quidel Company Details
Table 120. Quidel Business Overview
Table 121. Quidel Healthcare-associated Infectious Disease Diagnostics Product
Table 122. Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 123. Quidel Recent Developments
Table 124. Thermo Fisher Scientific Company Details
Table 125. Thermo Fisher Scientific Business Overview
Table 126. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product
Table 127. Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 128. Thermo Fisher Scientific Recent Developments
Table 129. Trinity Biotech Company Details
Table 130. Trinity Biotech Business Overview
Table 131. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product
Table 132. Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 133. Trinity Biotech Recent Developments
Table 134. Danaher Company Details
Table 135. Danaher Business Overview
Table 136. Danaher Healthcare-associated Infectious Disease Diagnostics Product
Table 137. Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 138. Danaher Recent Developments
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. Urinary Tract Infections Features
Figure 3. Surgical Site Infections Features
Figure 4. Hospital-acquired Pneumonia Features
Figure 5. BloodStream Infections Features
Figure 6. Gastrointestinal Infections Features
Figure 7. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2021 VS 2028
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. ASCs Case Studies
Figure 11. Healthcare-associated Infectious Disease Diagnostics Report Years Considered
Figure 12. Global Healthcare-associated Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Healthcare-associated Infectious Disease Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region: 2021 VS 2028
Figure 15. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players in 2021
Figure 16. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue in 2021
Figure 18. North America Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 20. North America Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 21. North America Healthcare-associated Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
Figure 22. United States Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 26. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 27. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
Figure 28. Germany Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size Share by Region (2017-2028)
Figure 38. China Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
Figure 48. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
Figure 54. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Abbott Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 58. Accelerate Diagnostics Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 59. BD Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 60. bioMrieux Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 61. Bio-Rad Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 62. DiaSorin Molecular Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 63. F. Hoffmann-La Roche Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 64. Luminex Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 65. Meridian Bioscience Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 66. OpGen Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 67. QIAGEN Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 68. Quidel Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 69. Thermo Fisher Scientific Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 70. Trinity Biotech Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 71. Danaher Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount